根据ESI于2021年1月21日发布的数据，我校高被引论文（Highly Cited Papers）167篇，热点论文（Hot Papers）14篇，见附件：2021年1月南方医科大学高被引论文及热点论文简表。详情如下。
从学科角度看，在167篇高被引论文中，临床医学最多（95篇），占比56.89%，分子生物学与遗传学（19篇）第二，占比11.38%，生物学与生物化学12篇（7.19%）紧跟其后。
|
序号 |
高被引论文 Research Field |
202101 |
202011 |
||
|
论文数 |
占比 |
论文数 |
占比 |
||
|
1 |
CLINICAL MEDICINE |
95 |
56.89% |
91 |
60.67% |
|
2 |
MOLECULAR BIOLOGY & GENETICS |
19 |
11.38% |
15 |
10.00% |
|
3 |
BIOLOGY & BIOCHEMISTRY |
12 |
7.19% |
11 |
7.33% |
|
4 |
PHARMACOLOGY & TOXICOLOGY |
10 |
5.99% |
8 |
5.33% |
|
5 |
NEUROSCIENCE & BEHAVIOR |
6 |
3.59% |
5 |
3.33% |
|
6 |
ENGINEERING |
2 |
1.20% |
2 |
1.33% |
|
7 |
MICROBIOLOGY |
6 |
3.59% |
6 |
4.00% |
|
8 |
AGRICULTURAL SCIENCES |
1 |
0.60% |
1 |
0.67% |
|
9 |
CHEMISTRY |
4 |
2.40% |
3 |
2.00% |
|
10 |
PHYSICS |
1 |
0.60% |
1 |
0.67% |
|
11 |
MATERIALS SCIENCE |
3 |
1.80% |
1 |
0.67% |
|
12 |
PSYCHIATRY/PSYCHOLOGY |
3 |
1.80% |
3 |
2.00% |
|
13 |
MULTIDISCIPLINARY |
1 |
0.60% |
1 |
0.67% |
|
14 |
IMMUNOLOGY |
0 |
0.00% |
0 |
0.00% |
|
15 |
ENVIRONMENT/ECOLOGY |
2 |
1.20% |
1 |
0.67% |
|
16 |
SOCIAL SCIENCES, GENERAL |
2 |
1.20% |
1 |
0.67% |
|
17 |
合计 |
167 |
100.00% |
150 |
100.00% |
|
序号 |
2021年1月我校14篇热点论文 标题 |
来源期刊 |
DOI |
Research Field |
Times Cited |
|
1 |
CLINICAL CHARACTERISTICS OF CORONAVIRUS DISEASE 2019 IN CHINA |
NEW ENGLAND JOURNAL OF MEDICINE 382 (18): 1708-1720 APR 30 2020 |
10.1056/NEJMoa2002032 |
CLINICAL MEDICINE |
4192 |
|
2 |
MINIMAL INFORMATION FOR STUDIES OF EXTRACELLULAR VESICLES 2018 (MISEV2018): A POSITION STATEMENT OF THE INTERNATIONAL SOCIETY FOR EXTRACELLULAR VESICLES AND UPDATE OF THE MISEV2014 GUIDELINES |
JOURNAL OF EXTRACELLULAR VESICLES 7 (1): - NOV 23 2018 |
10.1080/20013078.2018.1535750 |
BIOLOGY & BIOCHEMISTRY |
1145 |
|
3 |
ALIROCUMAB AND CARDIOVASCULAR OUTCOMES AFTER ACUTE CORONARY SYNDROME |
NEW ENGLAND JOURNAL OF MEDICINE 379 (22): 2097-2107 NOV 29 2018 |
10.1056/NEJMoa1801174 |
CLINICAL MEDICINE |
537 |
|
4 |
CORONAVIRUS INFECTIONS AND IMMUNE RESPONSES |
JOURNAL OF MEDICAL VIROLOGY 92 (4): 424-432 SP. ISS. SI APR 2020 |
10.1002/jmv.25685 |
MICROBIOLOGY |
310 |
|
5 |
INHIBITION OF SARS-COV-2 (PREVIOUSLY 2019-NCOV) INFECTION BY A HIGHLY POTENT PAN-CORONAVIRUS FUSION INHIBITOR TARGETING ITS SPIKE PROTEIN THAT HARBORS A HIGH CAPACITY TO MEDIATE MEMBRANE FUSION |
CELL RESEARCH 30 (4): 343-355 APR 2020 |
10.1038/s41422-020-0305-x |
MOLECULAR BIOLOGY & GENETICS |
133 |
|
6 |
PROTEOMICS IDENTIFIES NEW THERAPEUTIC TARGETS OF EARLY-STAGE HEPATOCELLULAR CARCINOMA |
NATURE 567 (7747): 257-+ MAR 14 2019 |
10.1038/s41586-019-0987-8 |
MULTIDISCIPLINARY |
120 |
|
7 |
CHARACTERISTICS OF AND PUBLIC HEALTH RESPONSES TO THE CORONAVIRUS DISEASE 2019 OUTBREAK IN CHINA |
JOURNAL OF CLINICAL MEDICINE 9 (2): - FEB 2020 |
10.3390/jcm9020575 |
CLINICAL MEDICINE |
105 |
|
8 |
PROGRESSION OF MENTAL HEALTH SERVICES DURING THE COVID-19 OUTBREAK IN CHINA |
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 16 (10): 1732-1738 2020 |
10.7150/ijbs.45120 |
BIOLOGY & BIOCHEMISTRY |
102 |
|
9 |
THE CHINESE SOCIETY OF CLINICAL ONCOLOGY (CSCO): CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF GASTRIC CANCER |
CANCER COMMUNICATIONS 39: - MAR 18 2019 |
10.1186/s40880-019-0349-9 |
CLINICAL MEDICINE |
66 |
|
10 |
DEVELOPMENT AND VALIDATION OF A CLINICAL RISK SCORE TO PREDICT THE OCCURRENCE OF CRITICAL ILLNESS IN HOSPITALIZED PATIENTS WITH COVID-19 |
JAMA INTERNAL MEDICINE 180 (8): 1081-1089 AUG 2020 |
10.1001/jamainternmed.2020.2033 |
CLINICAL MEDICINE |
53 |
|
11 |
REMDESIVIR FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 CAUSING COVID-19: AN EVALUATION OF THE EVIDENCE |
TRAVEL MEDICINE AND INFECTIOUS DISEASE 35: - MAY-JUN 2020 |
10.1016/j.tmaid.2020.101647 |
SOCIAL SCIENCES, GENERAL |
42 |
|
12 |
SURVEY OF INSOMNIA AND RELATED SOCIAL PSYCHOLOGICAL FACTORS AMONG MEDICAL STAFF INVOLVED IN THE 2019 NOVEL CORONAVIRUS DISEASE OUTBREAK |
FRONTIERS IN PSYCHIATRY 11: - APR 14 2020 |
10.3389/fpsyt.2020.00306 |
PSYCHIATRY/PSYCHOLOGY |
39 |
|
13 |
THE PREVALENCE AND INFLUENCING FACTORS IN ANXIETY IN MEDICAL WORKERS FIGHTING COVID-19 IN CHINA: A CROSS-SECTIONAL SURVEY |
EPIDEMIOLOGY AND INFECTION 148: - 2020 |
10.1017/S0950268820001107 |
SOCIAL SCIENCES, GENERAL |
14 |
|
14 |
MICRO-/NANOMOTORS TOWARD BIOMEDICAL APPLICATIONS: THE RECENT PROGRESS IN BIOCOMPATIBILITY |
SMALL 16 (27): - SP. ISS. SI JUL 2020 |
10.1002/smll.201906184 |
MATERIALS SCIENCE |
11 |
